Spearhead Capital Advisors’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,908	Closed	-$389K	–	223
2021 Q4	$389K	Buy	11,908 +670	+6%	+$21.9K	0.05%	125
2021 Q3	$471K	Buy	11,238 +536	+5%	+$22.5K	0.06%	105
2021 Q2	$416K	Buy	10,702 +1,694	+19%	+$65.8K	0.06%	135
2021 Q1	$307K	Buy	+9,008	New	+$307K	0.05%	165